
Journal of labelled compounds and radiopharmaceuticals p. 13 - 19 (2001)
Update date:2022-08-17
Topics:
Burgada
Bailly
Noel
Gomis
Valleix
Ansoborlo
Henge-Napoli
Paquet
Gourmelon
3,4,3 LI 1,2 HOPO 1 or LIHOPO (1,5,10,14-tetra (1-hydroxy-2-pyridone-6-oyl)-1,5,10,14-tetraazatetradecane.) is a decorporation agent used against actinides. It was synthesised labelled with carbon 14 with a view to metabolism studies. [6,9-14C]-LIHOPO 2 was obtained in two radioactive steps through a very convenient synthesis in 50% radioactive yield from commercially available [1,4-14C]-spermine, hydrochloride and 1-benzyloxy-6-oxo-1,6-dihydropyridine-2-carbonyl chloride 7. The synthesis of 7 is also described.
View More
Hubei Honch Pharmaceutical Co.,Ltd
Contact:86-713-7222018
Address:Li Shizhen Pharmaceutical Industry park, Qichun County, Hubei Province,China
Nanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Nanjing Chemical Material Corp.(NCMC)
website:http://www.njchemm.com
Contact:0086-25-83172879
Address:B12 Technology and Innovation Building, Nanjing Tech University, No.5 New Model Road
Contact:+86-28-88523492
Address:714rooms of Time Square, Pujiang County
website:http://www.shochem.com
Contact:021-50800795
Address:No.1043, Halei Rd, Zhangjiang Hi-Tech Park, Shanghai, Postcode 201203, China
Doi:10.1097/01.LAB.0000017169.26718.5F
(1952)Doi:10.1002/1521-3773(20010216)40:4<779::AID-ANIE7790>3.0.CO;2-1
(2001)Doi:10.1021/ja01177a515
(1949)Doi:10.1021/jo01077a036
(1960)Doi:10.1021/acs.joc.8b02669
(2019)Doi:10.1007/s10593-006-0268-y
(2006)